Pharma Raises Stakes in Digital Health

> Click To Read

Despite its many benefits, there are several Pharmaceutical companies that haven’t defined a solid strategy when it comes to working with digital health, or digital health companies. The digital health world is continuously developing and many Pharmaceutical companies are still trying to determine their investment strategy, as well as methods to measure success. According to ZS Principal Pete Masloski, companies that have determined digital health a worthy investment, often establish some type of separate organization internally that can focus on the evolution and appropriate role of digital health. In this article, Pete offers examples of how Pharmaceutical companies should approach the usage of digital health and explains how to overcome typical obstacles.

Read this article to learn:

  • The possible functions of digital health within the Pharmaceutical industry
  • The FDA’s recent steps to promote the use of digital health
  • How digital health can help companies better understand the patient journey